151
|
Maki N, Komatsuda A, Wakui H, Oyama Y, Kodama T, Ohtani H, Kigawa A, Aiba N, Imai H, Motegi M, Yamaguchi A, Sawada K. A nonsense mutation (R220X) in the alpha-galactosidase A gene causes typical Fabry disease in both genders. Clin Nephrol 2005; 61:185-90. [PMID: 15077869 DOI: 10.5414/cnp61185] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
BACKGROUND Fabry disease is an X-linked recessive disorder resulting from a deficiency of lysosomal alpha-galactosidase A (alpha-Gal A). Chronic renal failure is an important cause of death in patients with Fabry disease. We report on patients with Fabry disease (a hemizygous male and his mother) due to a nonsense mutation (R220X) in the alpha-Gal A gene. METHODS The proband, a 41-year-old man, and his 71-year-old mother presented with renal and cardiac manifestations of Fabry disease. Histological examination and molecular analysis of the alpha-Gal A gene were performed. RESULTS Typical histological findings of Fabry disease were observed in a renal biopsy specimen from the proband and in renal and myocardial necropsy specimens from the mother. Sequencing of a full-length alpha-Gal A cDNA from the proband indicated a C-T transition at codon 220, resulting in substitution of the predictable termination for arginine (R220X). Examination of genomic alpha-Gal A DNA revealed that the proband was a hemizygote and the mother was a heterozygous carrier for the mutation. CONCLUSION This is the first detailed report of family members with Fabry disease due to a nonsense mutation (R220X) in the alpha-Gal A gene. Our study indicates that this mutation causes the typical disease in both genders.
Collapse
|
152
|
Aliu E, Andringa S, Aoki S, Argyriades J, Asakura K, Ashie R, Berns H, Bhang H, Blondel A, Borghi S, Bouchez J, Burguet-Castell J, Casper D, Cavata C, Cervera A, Cho KO, Choi JH, Dore U, Espinal X, Fechner M, Fernandez E, Fukuda Y, Gomez-Cadenas J, Gran R, Hara T, Hasegawa M, Hasegawa T, Hayashi K, Hayato Y, Helmer RL, Hill J, Hiraide K, Hosaka J, Ichikawa AK, Iinuma M, Ikeda A, Inagaki T, Ishida T, Ishihara K, Ishii T, Ishitsuka M, Itow Y, Iwashita T, Jang HI, Jeon EJ, Jeong IS, Joo K, Jover G, Jung CK, Kajita T, Kameda J, Kaneyuki K, Kato I, Kearns E, Kerr D, Kim CO, Khabibullin M, Khotjantsev A, Kielczewska D, Kim JY, Kim S, Kitching P, Kobayashi K, Kobayashi T, Konaka A, Koshio Y, Kropp W, Kubota J, Kudenko Y, Kuno Y, Kutter T, Learned J, Likhoded S, Lim IT, Loverre PF, Ludovici L, Maesaka H, Mallet J, Mariani C, Maruyama T, Matsuno S, Matveev V, Mauger C, McConnel K, McGrew C, Mikheyev S, Minamino A, Mine S, Mineev O, Mitsuda C, Miura M, Moriguchi Y, Morita T, Moriyama S, Nakadaira T, Nakahata M, Nakamura K, Nakano I, Nakaya T, Nakayama S, Namba T, Nambu R, Nawang S, Nishikawa K, Nitta K, Nova F, Novella P, Obayashi Y, Okada A, Okumura K, Oser SM, Oyama Y, Pac MY, Pierre F, Rodriguez A, Saji C, Sakuda M, Sanchez F, Sarrat A, Sasaki T, Scholberg K, Schroeter R, Sekiguchi M, Sharkey E, Shiozawa M, Shiraishi K, Sitjes G, Smy M, Sobel H, Stone J, Sulak L, Suzuki A, Suzuki Y, Takahashi T, Takenaga Y, Takeuchi Y, Taki K, Takubo Y, Tamura N, Tanaka M, Terri R, T'Jampens S, Tornero-Lopez A, Totsuka Y, Ueda S, Vagins M, Walter CW, Wang W, Wilkes RJ, Yamada S, Yamamoto S, Yanagisawa C, Yershov N, Yokoyama H, Yokoyama M, Yoo J, Yoshida M, Zalipska J. Evidence for muon neutrino oscillation in an accelerator-based experiment. PHYSICAL REVIEW LETTERS 2005; 94:081802. [PMID: 15783876 DOI: 10.1103/physrevlett.94.081802] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/09/2004] [Indexed: 05/24/2023]
Abstract
We present results for nu(mu) oscillation in the KEK to Kamioka (K2K) long-baseline neutrino oscillation experiment. K2K uses an accelerator-produced nu(mu) beam with a mean energy of 1.3 GeV directed at the Super-Kamiokande detector. We observed the energy-dependent disappearance of nu(mu), which we presume have oscillated to nu(tau). The probability that we would observe these results if there is no neutrino oscillation is 0.0050% (4.0 sigma).
Collapse
|
153
|
Ueha-Ishibashi T, Tatsuishi T, Iwase K, Nakao H, Umebayashi C, Nishizaki Y, Nishimura Y, Oyama Y, Hirama S, Okano Y. Property of thimerosal-induced decrease in cellular content of glutathione in rat thymocytes: a flow cytometric study with 5-chloromethylfluorescein diacetate. Toxicol In Vitro 2005; 18:563-9. [PMID: 15251173 DOI: 10.1016/j.tiv.2004.01.002] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2003] [Accepted: 01/07/2004] [Indexed: 10/26/2022]
Abstract
There is a concern on the part of public health community that adverse health consequences by thimerosal, a preservative in vaccines for infants, may occur among infants during immunization schedule. Therefore, the effect of thimerosal on cellular content of glutathione was examined on thymocytes obtained from 4-week-old rats using a flow cytometer and 5-chloromethylfluorescein diacetate. Thimerosal at concentrations ranging from 1 to 10 microM reduced the cellular content of glutathione in a concentration-dependent manner, and the complete depletion of cellular glutathione was observed when the cells were treated with 30 microM thimerosal. L-Cysteine significantly attenuated the actions of thimerosal to reduce the glutathione content and to increase the intracellular Ca2+ concentration. Prolonged incubation (24 h) with 1-3 microM thimerosal induced the apoptosis. The cytotoxic action of thimerosal was greatly augmented when the cells suffered oxidative stress induced by H2O2. It may be unlikely that thimerosal exerts potent cytotoxic action under the in vivo condition because the blood concentration of thimerosal after receiving vaccines does not seem to reach micromolar range and nonprotein thiols at micromolar concentrations are present in the blood.
Collapse
|
154
|
Tatsuishi T, Oyama Y, Iwase K, Yamaguchi JY, Kobayashi M, Nishimura Y, Kanada A, Hirama S. Polysorbate 80 increases the susceptibility to oxidative stress in rat thymocytes. Toxicology 2005; 207:7-14. [PMID: 15590117 DOI: 10.1016/j.tox.2004.07.020] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2004] [Revised: 07/27/2004] [Accepted: 07/27/2004] [Indexed: 10/26/2022]
Abstract
Effect of simultaneous application of polysorbate 80, a nonionic surfactant widely used in pharmaceutical products, and hydrogen peroxide on rat thymocytes was examined to see if polysorbate 80 increases the susceptibility to oxidative stress because this surfactant decreases the cellular content of glutathione. Polysorbate 80 at clinically-relevant concentrations increases the cytotoxicity of hydrogen peroxide under the in vitro condition. Result suggests that polysorbate 80 may increase the susceptibility of cells to oxidative stress.
Collapse
|
155
|
Iwase K, Oyama Y, Tatsuishi T, Yamaguchi JY, Nishimura Y, Kanada A, Kobayashi M, Maemura Y, Ishida S, Okano Y. Cremophor EL augments the cytotoxicity of hydrogen peroxide in lymphocytes dissociated from rat thymus glands. Toxicol Lett 2004; 154:143-8. [PMID: 15475188 DOI: 10.1016/j.toxlet.2004.08.003] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2004] [Revised: 08/03/2004] [Accepted: 08/03/2004] [Indexed: 10/26/2022]
Abstract
The pharmaceutical uses of cremophor EL, a non-ionic surfactant, are similar to those of polysorbate 80. In our previous study, polysorbate 80 exerted some adverse actions on rat thymocytes under in vitro condition. Therefore, the effects of cremophor EL on thymic lymphocytes were examined using a flow cytometer with appropriate fluorescent dyes. Cremophor EL at 10 microg/ml or more (up to 300 microg/ml) concentration-dependently decreased cellular content of glutathione. The cell viability of thymocytes under control condition was 95.4 +/- 1.2% (n = 7, mean +/- S.D.). The incubation of thymocytes with 300 microg/ml cremophor EL or 3 mM hydrogen peroxide for 2 h, respectively, decreased the cell viability to 90.8 +/- 2.8% or 91.2 +/- 2.6%. However, the simultaneous incubation with cremophor EL and hydrogen peroxide decreased the cell viability to 28.7 +/- 8.2%. Cremophor EL at 100 microg/ml accelerated the process of cell death induced by hydrogen peroxide. Results suggest that cremophor EL increases the susceptibility to oxidative stress. Cremophor EL at clinically relevant concentrations may increase the therapeutic potential of some anticancer agents to produce oxidative stress.
Collapse
|
156
|
Iwase K, Tatsuishi T, Nishimura Y, Yamaguchi JY, Oyama Y, Miyoshi N, Wada M. Cytometric analysis of adverse action of diphenyl ditelluride on rat thymocytes: cell shrinkage as a cytotoxic parameter. ENVIRONMENTAL TOXICOLOGY 2004; 19:614-619. [PMID: 15526268 DOI: 10.1002/tox.20070] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
Despite the growing use of organotellurium compounds in the chemical and biomedical fields, there has been no great concern about their toxicity until now. To test the possibility that diphenyl ditelluride (DPDT) and tellurium chloride (TeCl2), organic and inorganic tellurium compounds, may exert adverse action on mammals, their effects on rat thymocytes were examined under in vitro conditions using a flow cytometer with fluorescent probes. Incubation of thymocytes with DPDT at 300 nM or more for 24 h significantly increased the populations of shrunken cells and of cells with hypodiploidal DNA. Z-VAD-FMK, a paninhibitor of caspases, greatly suppressed the DPDT-induced increase in the hypodiploidal cell population, suggesting the involvement of caspase activation in DPDT toxicity. Hence, it is possible that DPDT would increase the population of thymocytes undergoing apoptosis if the blood concentration in mammals reached at least 300 nM or more. TeCl2 was much less potent than DPDT in increasing the population of hypodiploidal cells.
Collapse
|
157
|
Oyama Y, Parker ER, Brieva J, Guitart J, Statkute L, Verda L, Burt RK. High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory pemphigus foliaceus. Bone Marrow Transplant 2004; 34:1097-8. [PMID: 15489875 DOI: 10.1038/sj.bmt.1704679] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
158
|
Ashie Y, Hosaka J, Ishihara K, Itow Y, Kameda J, Koshio Y, Minamino A, Mitsuda C, Miura M, Moriyama S, Nakahata M, Namba T, Nambu R, Obayashi Y, Shiozawa M, Suzuki Y, Takeuchi Y, Taki K, Yamada S, Ishitsuka M, Kajita T, Kaneyuki K, Nakayama S, Okada A, Okumura K, Ooyabu T, Saji C, Takenaga Y, Desai S, Kearns E, Likhoded S, Stone JL, Sulak LR, Walter CW, Wang W, Goldhaber M, Casper D, Cravens JP, Gajewski W, Kropp WR, Liu DW, Mine S, Smy MB, Sobel HW, Sterner CW, Vagins MR, Ganezer KS, Hill J, Keig WE, Jang JS, Kim JY, Lim IT, Ellsworth RW, Tasaka S, Guillian G, Kibayashi A, Learned JG, Matsuno S, Takemori D, Messier MD, Hayato Y, Ichikawa AK, Ishida T, Ishii T, Iwashita T, Kobayashi T, Maruyama T, Nakamura K, Nitta K, Oyama Y, Sakuda M, Totsuka Y, Suzuki AT, Hasegawa M, Hayashi K, Inagaki T, Kato I, Maesaka H, Morita T, Nakaya T, Nishikawa K, Sasaki T, Ueda S, Yamamoto S, Haines TJ, Dazeley S, Hatakeyama S, Svoboda R, Blaufuss E, Goodman JA, Sullivan GW, Turcan D, Scholberg K, Habig A, Fukuda Y, Jung CK, Kato T, Kobayashi K, Malek M, Mauger C, McGrew C, Sarrat A, Sharkey E, Yanagisawa C, Toshito T, Miyano K, Tamura N, Ishii J, Kuno Y, Nagashima Y, Takita M, Yoshida M, Kim SB, Yoo J, Okazawa H, Ishizuka T, Choi Y, Seo HK, Gando Y, Hasegawa T, Inoue K, Shirai J, Suzuki A, Koshiba M, Nakajima Y, Nishijima K, Harada T, Ishino H, Nishimura R, Watanabe Y, Kielczewska D, Zalipska J, Berns HG, Gran R, Shiraishi KK, Stachyra A, Washburn K, Wilkes RJ. Evidence for an oscillatory signature in atmospheric neutrino oscillations. PHYSICAL REVIEW LETTERS 2004; 93:101801. [PMID: 15447395 DOI: 10.1103/physrevlett.93.101801] [Citation(s) in RCA: 51] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/27/2004] [Indexed: 05/14/2023]
Abstract
Muon neutrino disappearance probability as a function of neutrino flight length L over neutrino energy E was studied. A dip in the L/E distribution was observed in the data, as predicted from the sinusoidal flavor transition probability of neutrino oscillation. The observed L/E distribution constrained nu(micro)<-->nu(tau) neutrino oscillation parameters; 1.9x10(-3)<Deltam(2)<3.0x10(-3) eV(2) and sin((2)2theta>0.90 at 90% confidence level.
Collapse
|
159
|
Ahn MH, Aoki S, Ashie Y, Bhang H, Boyd S, Casper D, Choi JH, Fukuda S, Fukuda Y, Gran R, Hara T, Hasegawa M, Hasegawa T, Hayashi K, Hayato Y, Hill J, Ichikawa AK, Ikeda A, Inagaki T, Ishida T, Ishii T, Ishitsuka M, Itow Y, Iwashita T, Jang HI, Jang JS, Jeon EJ, Joo KK, Jung CK, Kajita T, Kameda J, Kaneyuki K, Kato I, Kearns E, Kibayashi A, Kielczewska D, Kim BJ, Kim CO, Kim JY, Kim SB, Kobayashi K, Kobayashi T, Koshio Y, Kropp WR, Learned JG, Lim SH, Lim IT, Maesaka H, Maruyama T, Matsuno S, Mauger C, Mcgrew C, Minamino A, Mine S, Miura M, Miyano K, Morita T, Moriyama S, Nakahata M, Nakamura K, Nakano I, Nakata F, Nakaya T, Nakayama S, Namba T, Nambu R, Nishikawa K, Nishiyama S, Noda S, Obayashi Y, Okada A, Oyama Y, Pac MY, Park H, Saji C, Sakuda M, Sarrat A, Sasaki T, Sasao N, Scholberg K, Sekiguchi M, Sharkey E, Shiozawa M, Shiraishi KK, Smy M, Sobel HW, Stone JL, Suga Y, Sulak LR, Suzuki A, Suzuki Y, Takeuchi Y, Tamura N, Tanaka M, Totsuka Y, Ueda S, Vagins MR, Walter CW, Wang W, Wilkes RJ, Yamada S, Yamamoto S, Yanagisawa C, Yokoyama H, Yoo J, Yoshida M, Zalipska J. Search for electron neutrino appearance in a 250 km long-baseline experiment. PHYSICAL REVIEW LETTERS 2004; 93:051801. [PMID: 15323684 DOI: 10.1103/physrevlett.93.051801] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/10/2004] [Indexed: 05/24/2023]
Abstract
We present a search for electron neutrino appearance from accelerator-produced muon neutrinos in the K2K long-baseline neutrino experiment. One candidate event is found in the data corresponding to an exposure of 4.8 x 10(19) protons on target. The expected background in the absence of neutrino oscillations is estimated to be 2.4+/-0.6 events and is dominated by misidentification of events from neutral current pi(0) production. We exclude the nu(micro) to nu(e) oscillations at 90% C.L. for the effective mixing angle in the 2-flavor approximation of sin((2)2theta(microe)( approximately 1/2sin((2)2theta(13))>0.15 at Deltam(2)(microe)=2.8 x 10(-3) eV(2), the best-fit value of the nu(micro) disappearance analysis in K2K. The most stringent limit of sin((2)2theta(microe)<0.09 is obtained at Deltam(2)(microe)=6 x 10(-3) eV(2).
Collapse
|
160
|
Liu DW, Ashie Y, Fukuda S, Fukuda Y, Ishihara K, Itow Y, Koshio Y, Minamino A, Miura M, Moriyama S, Nakahata M, Namba T, Nambu R, Obayashi Y, Sakurai N, Shiozawa M, Suzuki Y, Takeuchi H, Takeuchi Y, Yamada S, Ishitsuka M, Kajita T, Kaneyuki K, Nakayama S, Okada A, Ooyabu T, Saji C, Desai S, Earl M, Kearns E, Messier MD, Stone JL, Sulak LR, Walter CW, Wang W, Barszczak T, Casper D, Cravens JP, Gajewski W, Kropp WR, Mine S, Smy MB, Sobel HW, Sterner CW, Vagins MR, Ganezer KS, Hill J, Keig WE, Kim JY, Lim IT, Ellsworth RW, Tasaka S, Kibayashi A, Learned JG, Matsuno S, Takemori D, Hayato Y, Ichikawa AK, Ishida T, Ishii T, Iwashita T, Kameda J, Kobayashi T, Maruyama T, Nakamura K, Nitta K, Oyama Y, Sakuda M, Totsuka Y, Suzuki AT, Hasegawa M, Hayashi K, Inagaki T, Kato I, Maesaka H, Morita T, Nakaya T, Nishikawa K, Sasaki T, Ueda S, Yamamoto S, Haines TJ, Dazeley S, Hatakeyama S, Svoboda R, Blaufuss E, Goodman JA, Guillian G, Sullivan GW, Turcan D, Scholberg K, Habig A, Ackermann M, Jung CK, Kato T, Kobayashi K, Martens K, Malek M, Mauger C, McGrew C, Sharkey E, Viren B, Yanagisawa C, Toshito T, Mitsuda C, Miyano K, Shibata T, Ishii J, Kajiyama Y, Kuno Y, Nagashima Y, Takita M, Yoshida M, Kim HI, Kim SB, Yoo J, Okazawa H, Ishizuka T, Choi Y, Seo HK, Gando Y, Hasegawa T, Inoue K, Shirai J, Suzuki A, Koshiba M, Hashimoto T, Nakajima Y, Nishijima K, Ishino H, Morii M, Nishimura R, Watanabe Y, Kielczewska D, Zalipska J, Gran R, Shiraishi KK, Washburn K, Wilkes RJ. Limits on the neutrino magnetic moment using 1496 days of Super-Kamiokande-I solar neutrino data. PHYSICAL REVIEW LETTERS 2004; 93:021802. [PMID: 15323899 DOI: 10.1103/physrevlett.93.021802] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/07/2004] [Indexed: 05/24/2023]
Abstract
A search for a nonzero neutrino magnetic moment has been conducted using 1496 live days of solar neutrino data from Super-Kamiokande-I. Specifically, we searched for distortions to the energy spectrum of recoil electrons arising from magnetic scattering due to a nonzero neutrino magnetic moment. In the absence of a clear signal, we found micro(nu)</=(3.6x10(-10))micro(B) at 90% C.L. by fitting to the Super-Kamiokande day-night spectra. The fitting took into account the effect of neutrino oscillation on the shapes of energy spectra. With additional information from other solar neutrino and KamLAND experiments constraining the oscillation region, a limit of micro(nu)</=(1.1x10(-10))micro(B) at 90% C.L. was obtained.
Collapse
|
161
|
Hirama S, Tatsuishi T, Iwase K, Nakao H, Umebayashi C, Nishizaki Y, Kobayashi M, Ishida S, Okano Y, Oyama Y. Flow-cytometric analysis on adverse effects of polysorbate 80 in rat thymocytes. Toxicology 2004; 199:137-43. [PMID: 15147788 DOI: 10.1016/j.tox.2004.02.017] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Revised: 02/09/2004] [Accepted: 02/09/2004] [Indexed: 11/28/2022]
Abstract
The effects of polysorbate 80, a non-ionic surfactant widely used in pharmaceutical products, on rat thymocytes were examined to reveal its toxic property at the cellular level. Polysorbate 80 at concentrations of 1-100 microg/ml did not significantly affect the cell viability. This surfactant at 30 microg/ml or more augmented the intensity of fluo-3 fluorescence, indicating the increase in intracellular Ca(2+) concentration. Such an augmentation of fluo-3 fluorescence by polysorbate 80 was not seen under the Ca(2+)-free condition, suggesting that polysorbate 80 increased membrane Ca(2+) permeability. The concentration-dependent polysorbate 80 at 10 microg/ml or more attenuated the intensity of 5-chloromethylfluorescein, indicating a decrease in cellular content of glutathione by polysorbate 80. Furthermore, the agent at 1 microg/ml or more attenuated the intensity of bis-(1,3-dibutylbarbituric acid) trimethine oxonol fluorescence, being independent from the changes in membrane potential. This phenomenon indicates that polysorbate 80 at 1 microg/ml or more may attenuate the incorporation of anionic compounds into the membranes. It can be suggested that polysorbate 80 modifies some of membranes and intracellular physiological parameters without affecting the cell viability.
Collapse
|
162
|
Kusakabe H, Sakamaki T, Nihei K, Oyama Y, Yanagimoto S, Ichimiya M, Kimura J, Toyama Y. Osseointegration of a hydroxyapatite-coated multilayered mesh stem. Biomaterials 2004; 25:2957-69. [PMID: 14967528 DOI: 10.1016/j.biomaterials.2003.09.090] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2003] [Accepted: 09/22/2003] [Indexed: 11/21/2022]
Abstract
A new type of porous coating for hip prostheses called "multilayered mesh" was tested under weight-bearing conditions. The surface of the stem is constructed of titanium mesh produced by etching. The hip stems of hydroxyapatite (HA)-coated multilayered mesh and conventional beads were implanted into canine right hips, and animals were killed 3, 6 and 10 weeks and 6 and 12 months after implantation. Shear strength between the implant and the bone was evaluated by the push-out test. Bone ingrowth was calculated from backscattered electron imaging-scanning electron microscopy (BEI-SEM) images of transverse sections. Toluidine blue stained sections and the BEI-SEM images were evaluated histologically. The break sites of the specimens after the push-out test were evaluated on BEI-SEM images of longitudinal sections. The mean push-out strength of the HA-coated multilayered mesh samples was greater than that of the beads-coated samples every time tested, and the HA-coated multilayered mesh implants had significantly stronger push-out strength at 3 and 6 weeks (p<0.05). The strength of the HA-coated multilayered mesh implants was even greater at 6 and 12 months, whereas the strength of the beads-coated samples decreased. The HA-coated multilayered mesh implants showed significantly higher percentages of bone ingrowth than the beads-coated implants every time tested, except at 6 months (p<0.05). At 6 and 12 months, the bone ingrowth data for the HA-coated multilayered mesh implants increased, whereas it decreased for the beads-coated implants. The new bone formation had reached the bottom of the porous area of the HA-coated multilayered mesh surface by 3 weeks, but not had reached the bottom of the conventional beads surface. At 6 and 12 months, the smaller pores of the bead surface stopped the thickening of trabecular bone, and at 12 months, the break sites were at the bone-implant interface of the bead surface, whereas they were on the bone side of the HA-coated multilayered mesh surface. The difference between the break sites was significant at 12 months (p<0.05). The HA-coated multilayered mesh stem provided faster, stronger, and more durable osseointegration than the conventional bead stem.
Collapse
|
163
|
Umebayashi C, Oyama Y, Chikahisa-Muramastu L, Nakao H, Nishizaki Y, Nakata M, Soeda F, Takahama K. Tri-n-butyltin-induced cytotoxicity on rat thymocytes in presence and absence of serum. Toxicol In Vitro 2004; 18:55-61. [PMID: 14630062 DOI: 10.1016/j.tiv.2003.08.003] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Influence of fetal bovine serum (FBS) on cytotoxicity induced by tri-n-butyltin (TBT), an environmental pollutant, on rat thymocytes was examined to reveal how FBS modifies TBT cytotoxicity. As the medium FBS concentration was increased from 0 to 10%, the cytotoxicity of TBT was dose-dependently reduced when the cells were incubated with 1 microM TBT for 3 h. Almost complete inhibitions of TBT-induced changes in cell viability and population of cells with exposed phosphatidylserine (cells undergoing apoptosis) were observed when the FBS concentration was 10%. Thus, the cytotoxicity induced by 3 h incubation with TBT in FBS-free medium may be different from that in medium containing 10% FBS. However, even in presence of 10% FBS, TBT at concentrations ranging from 10 to 300 nM exerted cytotoxic action on rat thymocytes when the cells were incubated with TBT for 24 h. TBT dose-dependently increased the population of shrunken cells, of which more than 30% were stained with propidium. TBT at 30 nM or more significantly increased the population of cells with hypodiploid DNA, indicating TBT-induced apoptotic cell death. Thus, in the presence of 10% FBS, the prolonged incubation (24 h) of rat thymocytes with TBT at nanomolar concentrations induced apoptosis rather than necrosis.
Collapse
|
164
|
Burt R, Oyama Y, Verda L. Embryonic stem cells as an alternative donor marrow source: engraftment without GVHD. Biol Blood Marrow Transplant 2004. [DOI: 10.1016/j.bbmt.2003.12.084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
165
|
Ueha-Ishibashi T, Oyama Y, Nakao H, Umebayashi C, Nishizaki Y, Tatsuishi T, Iwase K, Murao K, Seo H. Effect of thimerosal, a preservative in vaccines, on intracellular Ca2+ concentration of rat cerebellar neurons. Toxicology 2004; 195:77-84. [PMID: 14698570 DOI: 10.1016/j.tox.2003.09.002] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The effect of thimerosal, an organomercurial preservative in vaccines, on cerebellar neurons dissociated from 2-week-old rats was compared with those of methylmercury using a flow cytometer with appropriate fluorescent dyes. Thimerosal and methylmercury at concentrations ranging from 0.3 to 10 microM increased the intracellular concentration of Ca2+ ([Ca2+]i) in a concentration-dependent manner. The potency of 10 microM thimerosal to increase the [Ca2+]i was less than that of 10 microM methylmercury. Their effects on the [Ca2+]i were greatly attenuated, but not completely suppressed, under external Ca(2+)-free condition, suggesting a possibility that both agents increase membrane Ca2+ permeability and release Ca2+ from intracellular calcium stores. The effect of 10 microM thimerosal was not affected by simultaneous application of 30 microM L-cysteine whereas that of 10 microM methylmercury was significantly suppressed. The potency of thimerosal was similar to that of methylmercury in the presence of L-cysteine. Both agents at 1 microM or more similarly decreased the cellular content of glutathione in a concentration-dependent manner, suggesting an increase in oxidative stress. Results indicate that thimerosal exerts some cytotoxic actions on cerebellar granule neurons dissociated from 2-week-old rats and its potency is almost similar to that of methylmercury.
Collapse
|
166
|
Nishizaki Y, Nakao H, Umebayashi C, Iwase K, Tatsuishi T, Satoh M, Oyama Y. Increase in number of annexin V-positive living cells of rat thymocytes by intracellular Pb(2+). ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY 2003; 15:45-51. [PMID: 21782679 DOI: 10.1016/j.etap.2003.08.007] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/01/2003] [Accepted: 08/19/2003] [Indexed: 05/31/2023]
Abstract
Lead is ubiquitous in our environment and lead poisoning is a major public health problem worldwide. In this study, to see if intracellular Pb(2+) induces the exposure of phosphatidylserine in rat thymocyte membranes, we have examined the effect of PbCl(2) on rat thymocytes treated with A23187 using a flow cytometer with appropriate fluorescent indicators under nominally-Ca(2+)-free condition. PbCl(2) at 1-30 μM dose-dependently induced the exposure of phosphatidylserine on outer membranes, associated with increasing the concentration of intracellular Pb(2+). The potency of intracellular Pb(2+) to induce the apoptotic change in thymocyte membranes seems to be greater than those of intracellular Ca(2+) and Cd(2+). Results suggest that intracellular Pb(2+) triggers apoptosis of rat thymocytes. This action of Pb(2+) may be one of mechanisms for the lead-induced changes in immunity.
Collapse
|
167
|
Nishizaki Y, Oyama Y, Sakai Y, Hirama S, Tomita K, Nakao H, Umebayashi C, Ishida S, Okano Y, Carpenter DO. PbCl2-induced hyperpolarization of rat thymocytes: involvement of charybdotoxin-sensitive K+ channels. ENVIRONMENTAL TOXICOLOGY 2003; 18:321-326. [PMID: 14502585 DOI: 10.1002/tox.10132] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
The effect of PbCl2 on membrane potential and intracellular divalent metal cation concentrations of rat thymocytes was examined by flow cytometry. PbCl2 at concentrations of 0.3 microM or higher (up to 10 microM) produced persistent, dose-dependent hyperpolarization (decrease in the intensity of di-BA-C4 fluorescence). Removal of external Ca2+ did not significantly affect the PbCl2-induced hyperpolarization. Charybdotoxin, a specific antagonist of Ca(2+)-dependent K+ conductance, greatly attenuated the PbCl2-induced hyperpolarization. PbCl2 increased the intensity of fluo-3 fluorescence under both normal Ca2+ and nominally Ca(2+)-free conditions. These results suggest that Pb2+ enters thymocytes, causing an increase in fluo-3 fluorescence, and activates Ca(2+)-dependent K+ channels, resulting in hyperpolarization. The persistent activation of K+ channels by Pb2+, leading to persistent hyperpolarization, may be one mechanism whereby Pb2+ alters immune function, as membrane potential changes influence physiological functions of lymphocytes.
Collapse
|
168
|
Burt RK, Arnold R, Emmons R, Oyama Y, Marmont A. Stem cell therapy for autoimmune disease: overview of concepts from the Snowbird 2002 tolerance and tissue regeneration meeting. Bone Marrow Transplant 2003; 32 Suppl 1:S3-5. [PMID: 12931231 DOI: 10.1038/sj.bmt.1703935] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Hematopoietic stem cell transplantation as a treatment for autoimmune disease began in 1996 and has subsequently spread worldwide. In Europe phase III trials have opened, while in America phase III trials are being designed and funded by the National Institutes of Health. On 6 June 2002, clinicians and scientists from around the world met at Snowbird, Utah to discuss the results and future directions of stem cell therapy for autoimmune diseases. What follows are general concepts from chairpersons of this meeting.
Collapse
|
169
|
Burt R, Pearce W, Luo K, Oyama Y, Davidson C, Beohar N, Gheorghiade M. Hematopoietic stem cell transplantation for cardiac and peripheral vascular disease. Bone Marrow Transplant 2003; 32 Suppl 1:S29-31. [PMID: 12931237 DOI: 10.1038/sj.bmt.1704177] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
Recent studies have suggested that marrow and blood hematopoietic stem cells may contribute to nonhematopoietic tissue repair in multiple organ systems. In animal models and more recently in limited human trials, unpurified marrow mononuclear cells and/or subsets of adult hematopoietic stem cells have been reported to contribute to neoangiogenesis. Since the subset of hematopoietic stem cells (HSCs) that are both CD34+ and AC133+ are endothelial cell precursors, clinical trials using autologous AC133+ HSCs isolated with the Miltenyi CLIMACS cell separator and transplanted into patients with ischemic and refractory peripheral vascular or coronary artery disease are being implemented at Northwestern University.
Collapse
|
170
|
Burt RK, Marmont A, Arnold R, Heipe F, Firestein GS, Carrier E, Hahn B, Barr W, Oyama Y, Snowden J, Kalunian K, Traynor A. Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus. Bone Marrow Transplant 2003; 32 Suppl 1:S49-51. [PMID: 12931242 DOI: 10.1038/sj.bmt.1703943] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
At Northwestern University, a phase I/II trial of hematopoietic stem cell transplant (HSCT) for systemic lupus erythematosus (SLE) has shown promising results. A phase III HSCT trial is being developed to confirm efficacy of HSCT vs continuing the currently accepted standard of care, intravenous pulse cyclophosphamide.
Collapse
|
171
|
Craig RM, Traynor A, Oyama Y, Burt RK. Hematopoietic stem cell transplantation for severe Crohn's disease. Bone Marrow Transplant 2003; 32 Suppl 1:S57-9. [PMID: 12931244 DOI: 10.1038/sj.bmt.1703945] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
It is clear that some patients with severe Crohn's disease (CD) fail to respond favorably to the standard treatment, including antibody to Tumor Necrosis Factor alpha (TNFalpha), We have embarked on a unique therapy for this group of patients, intense immune suppression followed by autologous hematopoietic stem cell transplantation (HSCT). The response to this approach in our first four patients has been excellent, with there being no significant untoward event from the transplantation and with each patient entering clinical remission in terms of the Crohn's Disease Activity Index off all therapy for CD and no diarrhea or abdominal pain. However, some evidence of minor laboratory abnormalities and slight inflammation of the colon on colonoscopic evaluation persist up to 1 year post-transplant. It is suggested that HSCT should be considered a reasonable option for patients who have failed standard CD therapy, although long-term follow-up will be necessary to confirm the duration of the induced clinical remission.
Collapse
|
172
|
Oyama Y, Traynor AE, Barr W, Burt RK. Allogeneic stem cell transplantation for autoimmune diseases: nonmyeloablative conditioning regimens. Bone Marrow Transplant 2003; 32 Suppl 1:S81-3. [PMID: 12931250 DOI: 10.1038/sj.bmt.1703950] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Hematopoietic stem cell transplantation (HSCT) for autoimmune diseases have been, because of safety reasons, overwhelmingly autologous. Results are, in general, encouraging with improvement in quality of life, a remission of up to several years, and perhaps in some diseases improved survival. This indicates that further study of autologous HSCT especially under phase III design is warranted. However, the ultimate goal of HSCT is cure of otherwise incurable autoimmune diseases. For this reason, allogeneic HSCT in carefully selected high-risk patients with autoimmune diseases using strategies to minimize both regimen-related toxicity and graft-versus-host disease (GVHD) is ongoing at Northwestern University and will be reviewed briefly.
Collapse
|
173
|
Masuda T, Oyama Y, Yamamoto N, Umebayashi C, Nakao H, Toi Y, Takeda Y, Nakamoto K, Kuninaga H, Nishizato Y, Nonaka A. Cytotoxic screening of medicinal and edible plants in Okinawa, Japan, and identification of the main toxic constituent of Rhodea japonica (Omoto). Biosci Biotechnol Biochem 2003; 67:1401-4. [PMID: 12843672 DOI: 10.1271/bbb.67.1401] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The cytotoxic activity of ethanol extracts from 53 parts of 36 species of medicinal and edible plants cultivated in Okinawa was measured by using K562 human leukemia cells by a flow cytometric method. Two extracts from Rhodea japonica and Hypericum chinense were cytotoxic at a concentration of 10 microg/ml. The main cytotoxic constituent of Rhodea japonica was isolated and identified to be rhodexin A, which has been isolated as a cardetonic agent of the plant. The IC(50) value for rhodexin A against the growth of K562 cells was 19 nM, this activity being much stronger than that of ouabain (IC(50), 60 nM).
Collapse
|
174
|
Gando Y, Fukuda S, Fukuda Y, Ishitsuka M, Itow Y, Kajita T, Kameda J, Kaneyuki K, Kobayashi K, Koshio Y, Miura M, Moriyama S, Nakahata M, Nakayama S, Namba T, Obayashi Y, Okada A, Ooyabu T, Saji C, Sakurai N, Shiozawa M, Suzuki Y, Takeuchi H, Takeuchi Y, Totsuka Y, Yamada S, Desai S, Earl M, Kearns E, Messier MD, Stone JL, Sulak LR, Walter CW, Goldhaber M, Barszczak T, Casper D, Gajewski W, Kropp WR, Mine S, Liu DW, Smy MB, Sobel HW, Vagins MR, Gago A, Ganezer KS, Hill J, Keig WE, Ellsworth RW, Tasaka S, Kibayashi A, Learned JG, Matsuno S, Takemori D, Hayato Y, Ichikawa AK, Ishii T, Kobayashi T, Maruyama T, Nakamura K, Oyama Y, Sakuda M, Yoshida M, Kohama M, Iwashita T, Suzuki AT, Inagaki T, Kato I, Nakaya T, Nishikawa K, Haines TJ, Dazeley S, Hatakeyama S, Svoboda R, Blaufuss E, Chen ML, Goodman JA, Guillian G, Sullivan GW, Turcan D, Scholberg K, Habig A, Ackermann M, Jung CK, Martens K, Malek M, Mauger C, McGrew C, Sharkey E, Viren B, Yanagisawa C, Toshito T, Mitsuda C, Miyano K, Shibata T, Kajiyama Y, Nagashima Y, Nitta K, Takita M, Kim HI, Kim SB, Yoo J, Okazawa H, Ishizuka T, Etoh M, Hasegawa T, Inoue K, Ishihara K, Shirai J, Suzuki A, Koshiba M, Hatakeyama Y, Ichikawa Y, Koike M, Nishijima K, Ishino H, Morii M, Nishimura R, Watanabe Y, Kielczewska D, Berns HG, Boyd SC, Stachyra AL, Wilkes RJ. Search for nu(e) from the sun at Super-Kamiokande-I. PHYSICAL REVIEW LETTERS 2003; 90:171302. [PMID: 12786067 DOI: 10.1103/physrevlett.90.171302] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/30/2002] [Indexed: 05/24/2023]
Abstract
We present the results of a search for low energy nu(e) from the Sun using 1496 days of data from Super-Kamiokande-I. We observe no significant excess of events and set an upper limit for the conversion probability to nu(e) of the 8B solar neutrino. This conversion limit is 0.8% (90% C.L.) of the standard solar model's neutrino flux for total energy=8-20 MeV. We also set a flux limit for monochromatic nu(e) for E(nu(e))=10-17 MeV.
Collapse
|
175
|
Ali MY, Oyama Y, Monreal J, Winter JN, Tallman MS, Williams SF, Singhal S, Gordon LI, Mehta J. Ideal or actual body weight to calculate CD34+ cell doses for autologous hematopoietic stem cell transplantation? Bone Marrow Transplant 2003; 31:861-4. [PMID: 12748662 DOI: 10.1038/sj.bmt.1703955] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
The number of CD34+ cells infused influences the speed of hematologic recovery post-transplant. There are limited data on whether ideal (IBW) or actual (ABW) body weight should be used to calculate CD34+ cell dose. We compared the correlation between recovery to 0.5 x 10(9)/l neutrophils and the CD34+ cell dose based upon ABW as well as IBW in 87 patients autografted for cancer. ABW was >or=25% over IBW in 43% of patients. The median number of CD34+ cells administered was 3.6 x 10(6)/kg ABW and 4.2 x 10(6)/kg IBW. The time to neutrophil recovery was 8-15 days (median 10). There was a stronger inverse correlation between CD34+ cell dose/IBW and neutrophil recovery (r(2)=0.308; P<0.0001) than between CD34+ cell dose/ABW and neutrophil recovery (r(2)=0.267; P<0.0001). The median time to neutrophil recovery was comparable for those receiving >or=2 x 10(6)/kg CD34+ cells/kg IBW as well as ABW (10 days) and those receiving >or=2 x 10(6)/kg CD34+ cells/kg IBW but <2/kg ABW (10 days), but was significantly slower for those receiving <2 x 10(6)/kg CD34+ cells/kg IBW (12 days). These data show that the CD34+ cell dose based on IBW is a better predictor of neutrophil recovery after autotransplantation.
Collapse
|